Dyadic International (DYAI) Return on Assets (2019 - 2026)
Dyadic International (DYAI) posted Return on Assets of 0.01% for Q1 2026, down 20.53% sequentially from 0.01% in Q4 2025, and little changed YoY from 0.01% in Q1 2025.
Dyadic International (DYAI) Return on Assets (2019 - 2026) Analysis & Trends
Dyadic International has reported Return on Assets for 8 years, with the latest figure at 0.01% in Q1 2026.
- Quarterly Return on Assets changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.03%, changed 0.0% from the prior year.
- Return on Assets slipped to 0.01% in Q1 2026 per DYAI's latest filing, from 0.01% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q2 2022 and troughed at 0.02% in Q3 2022.
- A 5-year average of 0.01% and a median of 0.01% in 2025 frame the typical range for Return on Assets.
- The sharpest annual moves came in 2022 and 2023: Return on Assets jumped 148 bps in 2022, then decreased 1 bps in 2023.
- Over 5 years, Return on Assets stood at 0.01% in 2022, then climbed by 26 bps to 0.01% in 2023, then surged by 43 bps to 0.01% in 2024, then slipped by 22 bps to 0.01% in 2025, then dropped by 21 bps to 0.01% in 2026.
- According to Business Quant data, Return on Assets over the past three periods registered 0.01%, 0.01%, and 0.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.08 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.11 Bn | 78.11 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.09 Bn | 50.96 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.49 Bn | 26.32 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 0.00% |
| 10 | Dyadic International | 19.89 Mn | 19.89 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | -1.49% |
| Sep 30, 2021 | -1.34% |
| Jun 30, 2021 | -1.22% |